Literature DB >> 30738046

Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis.

Shengbing Zhao1, Shuling Wang2, Peng Pan2, Tian Xia3, Xin Chang2, Xia Yang4, Liliangzi Guo5, Qianqian Meng6, Fan Yang2, Wei Qian2, Zhichao Xu2, Yuanqiong Wang2, Zhijie Wang2, Lun Gu2, Rundong Wang2, Fangzhou Jia2, Jun Yao7, Zhaoshen Li8, Yu Bai9.   

Abstract

BACKGROUND & AIMS: We performed a systematic review and meta-analysis to comprehensively estimate adenoma miss rate (AMR) and advanced AMR (AAMR) and explore associated factors.
METHODS: We searched the PubMed, Web of Science, and Ovid EMBASE databases for studies published through April 2018 on tandem colonoscopies, with AMR and AAMR as the primary outcomes. We performed meta-regression analyses to identify risk factors and factors associated with outcome. Primary outcomes were AMR and AAMR and secondary outcomes were AMR and AAMR for different locations, sizes, pathologies, morphologies, and populations.
RESULTS: In a meta-analysis of 43 publications and more than 15,000 tandem colonoscopies, we calculated miss rates of 26% for adenomas (95% confidence interval [CI] 23%-30%), 9% for advanced adenomas (95% CI 4%-16%), and 27% for serrated polyps (95% CI 16%-40%). Miss rates were high for proximal advanced adenomas (14%; 95% CI 5%-26%), serrated polyps (27%; 95% CI 16%-40%), flat adenomas (34%; 95% CI 24%-45%), and in patients at high risk for colorectal cancer (33%; 95% CI 26%-41%). Miss rates could be decreased by adequate bowel preparation and auxiliary techniques (P = .06; P = .04, and P = .01, respectively). The adenoma detection rate (ADR), adenomas per index colonoscopy, and adenomas per positive index colonoscopy (APPC) were independently associated with AMR (P = .02, P = .01, and P = .008, respectively), whereas APPC was the only factor independently associated with AAMR (P = .006). An APPC value greater than 1.8 was more effective in monitoring AMR (31% vs 15% for AMR P < .0001) than an ADR value of at least 34% (27% vs 17% for AMR; P = .008). The AAMR of colonoscopies with an APPC value below 1.7 was 35%, vs 2% for colonoscopies with an APPC value of at least 1.7 (P = .0005).
CONCLUSIONS: In a systematic review and meta-analysis, we found that adenomas and advanced adenomas are missed (based on AMR and AAMR) more frequently than previously believed. In addition to ADR, APPC deserves consideration as a complementary indicator of colonoscopy quality, if it is validated in additional studies.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interval Cancer; Missed Lesions; Prevention; Quality Indicators

Mesh:

Year:  2019        PMID: 30738046     DOI: 10.1053/j.gastro.2019.01.260

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  57 in total

1.  The enduring promise of phosphodiesterase 5 inhibitors for colon cancer prevention.

Authors:  Darren D Browning
Journal:  Transl Gastroenterol Hepatol       Date:  2019-12-23

2.  Does i-scan improve adenoma detection rate compared to high-definition colonoscopy? A systematic review and meta-analysis.

Authors:  Muhammad Aziz; Zohaib Ahmed; Hossein Haghbin; Asad Pervez; Hemant Goyal; Faisal Kamal; Abdallah Kobeissy; Ali Nawras; Douglas G Adler
Journal:  Endosc Int Open       Date:  2022-06-10

3.  Does computer-aided diagnostic endoscopy improve the detection of commonly missed polyps? A meta-analysis.

Authors:  Arun Sivananthan; Scarlet Nazarian; Lakshmana Ayaru; Kinesh Patel; Hutan Ashrafian; Ara Darzi; Nisha Patel
Journal:  Clin Endosc       Date:  2022-05-12

4.  High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.

Authors:  Reinier G S Meester; Iris Lansdorp-Vogelaar; Sidney J Winawer; Ann G Zauber; Amy B Knudsen; Uri Ladabaum
Journal:  Ann Intern Med       Date:  2019-09-24       Impact factor: 25.391

Review 5.  Progress Report: New insights into the prevention of CRC by colonoscopic surveillance in Lynch syndrome.

Authors:  Hans F A Vasen
Journal:  Fam Cancer       Date:  2021-01-19       Impact factor: 2.375

Review 6.  Artificial Intelligence in Lower Gastrointestinal Endoscopy: The Current Status and Future Perspective.

Authors:  Sebastian Manuel Milluzzo; Paola Cesaro; Leonardo Minelli Grazioli; Nicola Olivari; Cristiano Spada
Journal:  Clin Endosc       Date:  2021-01-13

7.  The use of the faecal immunochemical test during the COVID-19 pandemic to triage urgent colorectal cancer referrals.

Authors:  Faddy Kamel; Saadia Zulfiqar; WIlliam Penfold; Stephanie Weatherell; Rana Madani; Pasha Nisar; Philip Bearn
Journal:  Colorectal Dis       Date:  2022-03-31       Impact factor: 3.917

8.  Simple feedback of colonoscopy performance improved the number of adenomas per colonoscopy and serrated polyp detection rate.

Authors:  Osamu Toyoshima; Shuntaro Yoshida; Toshihiro Nishizawa; Tadahiro Yamakawa; Toru Arano; Yoshihiro Isomura; Takamitsu Kanazawa; Hidehiko Ando; Yosuke Tsuji; Kazuhiko Koike
Journal:  Endosc Int Open       Date:  2021-06-17

9.  COVID-19: impetus to the adoption of capsule endoscopy as a primary diagnostic tool?

Authors:  Mark McAlindon
Journal:  Frontline Gastroenterol       Date:  2021-02-24

Review 10.  Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions.

Authors:  Saleh Ramezani; Arianna Parkhideh; Pratip K Bhattacharya; Mary C Farach-Carson; Daniel A Harrington
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.